News Xbrane Biopharma AB Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
Oct. 28 | Redeye reiterates motivated value for Xbrane Biopharma | FW |
Oct. 24 | Xbrane Biopharma AB, Nine Months 2024 Earnings Call, Oct 24, 2024 |
Oct. 31 | PU | |
Oct. 28 | FW | |
Oct. 28 | AQ | |
Oct. 24 | ||
Oct. 24 | FW | |
Oct. 24 | AQ | |
Oct. 24 | CI | |
Oct. 22 | AQ | |
Oct. 22 | AQ | |
Oct. 21 | FW | |
Oct. 21 | FW | |
Oct. 21 | PU | |
Oct. 21 | AQ | |
Oct. 21 | AQ | |
Sep. 30 | AQ | |
Sep. 27 | FW | |
Sep. 27 | FW | |
Sep. 27 | AQ | |
Sep. 27 | CI | |
Aug. 30 | FW | |
Aug. 30 | FW | |
Aug. 30 | FW | |
Aug. 30 | AQ | |
Aug. 28 | ||
Aug. 28 | FW |
- Stock Market
- Equities
- XBRANE Stock
- Stock
- News Xbrane Biopharma AB